About the GRADUATE Study

You could qualify for the GRADUATE clinical study – a clinical study that will assess how safe and effective an investigational drug may be at slowing the progression of early or mild Alzheimer’s disease – if you:

are 50-90 years old

have mild Alzheimer’s disease or memory problems that may be the early symptoms of the condition

have someone you see frequently who is willing to act as your “Study Partner”

If these things are true, you could qualify. The GRADUATE study is sponsored by Genentech, a wholly owned member of the Roche Group.

Sign up for more information about the GRADUATE study

Fill out this form with your information and someone will reach out to you shortly about participating in the GRADUATE clinical study.